By Mariam Sunny and Christy Santhosh Nov 3 (Reuters) – Pfizer raised its full-year profit and revenue forecasts on Tuesday as strong demand for its recently acquired cancer drug Padcev and blockbuster
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
U.S. STOCK INDEXES EXTEND GAINS; S&P 500 UP 0.70%, NASDAQ UP 1.2% (The article has…
VIDEO SHOWS: HIGHLIGHTS FROM PARIS MASTERS ATP 1000 TOURNAMENT INCLUDING NOVAK DJOKOVIC V VALENTIN VACHEROT…
NEW YORK, Nov 3 (Reuters) - Marathon Petroleum beat Wall Street estimates for third-quarter profit…
By Elizabeth Howcroft and AJ Vicens PARIS/DETROIT, Nov 3 (Reuters) - Hackers used a bogus…
Nov 3 (Reuters) - Hamilton Lane Private Assets Fund : * HAMILTON LANE PRIVATE ASSETS…
Nov 3 (Reuters) - Italian Sea Group SpA: * TOTAL CURRENT LIABILITIES EUR 532.34 MILLION…